 |
PDBsum entry 2a1d
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/hydrolase inhibitor
|
PDB id
|
|
|
|
2a1d
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
41 a.a.
|
 |
|
|
|
|
|
|
|
259 a.a.
|
 |
|
|
|
|
|
|
|
282 a.a.
|
 |
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase/hydrolase inhibitor
|
 |
|
Title:
|
 |
Staphylocoagulase bound to bovine thrombin
|
|
Structure:
|
 |
Thrombin. Chain: a, e. Fragment: thrombin light chain. Synonym: coagulation factor ii. Thrombin. Chain: b, f. Fragment: thrombin heavy chain. Synonym: coagulation factor ii. Staphylocoagulase.
|
|
Source:
|
 |
Bos taurus. Cattle. Organism_taxid: 9913. Staphylococcus aureus. Organism_taxid: 1280. Expressed in: escherichia coli. Expression_system_taxid: 562
|
|
Biol. unit:
|
 |
Trimer (from
)
|
|
Resolution:
|
 |
|
3.50Å
|
R-factor:
|
0.233
|
R-free:
|
0.306
|
|
|
Authors:
|
 |
R.Friedrich,P.Panizzi,S.Kawabata,W.Bode,P.E.Bock,P.Fuentes-Prior
|
Key ref:
|
 |
R.Friedrich
et al.
(2006).
Structural basis for reduced staphylocoagulase-mediated bovine prothrombin activation.
J Biol Chem,
281,
1188-1195.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
20-Jun-05
|
Release date:
|
27-Sep-05
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P00735
(THRB_BOVIN) -
Prothrombin from Bos taurus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
625 a.a.
41 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains A, B, E, F:
E.C.3.4.21.5
- thrombin.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Preferential cleavage: Arg-|-Gly; activates fibrinogen to fibrin and releases fibrinopeptide A and B.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
281:1188-1195
(2006)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural basis for reduced staphylocoagulase-mediated bovine prothrombin activation.
|
|
R.Friedrich,
P.Panizzi,
S.Kawabata,
W.Bode,
P.E.Bock,
P.Fuentes-Prior.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Staphylocoagulase (SC) is a protein secreted by the human pathogen,
Staphylococcus aureus, that activates human prothrombin (ProT) by inducing a
conformational change. SC-bound ProT efficiently clots fibrinogen, thus
bypassing the physiological blood coagulation pathway. The crystal structure of
a fully active SC fragment, SC-(1-325), bound to human prethrombin 2 showed that
the SC-(1-325) N terminus inserts into the Ile(16) pocket of prethrombin 2,
thereby inducing expression of a functional catalytic site in the cognate
zymogen without peptide bond cleavage. As shown here, SC-(1-325) binds to bovine
and human ProT with similar affinity but activates the bovine zymogen only very
poorly. By contrast to the approximately 2-fold difference in chromogenic
substrate kinetic constants between human thrombin and the SC-(1-325).human
(pro)thrombin complexes, SC-(1-325).bovine ProT shows a 3,500-fold lower
k(cat)/K(m) compared with free bovine thrombin, because of a 47-fold increase in
K(m) and a 67-fold decrease in k(cat). The SC-(1-325).bovine ProT complex is
approximately 5,800-fold less active compared with its human counterpart.
Comparison of human and bovine fibrinogen as substrates of human and bovine
thrombin and the SC-(1-325).(pro)thrombin complexes indicates that the species
specificity of SC-(1-325) cofactor activity is determined primarily by
differences in conformational activation of bound ProT. These results suggest
that the catalytic site in the SC-(1-325).bovine ProT complex is incompletely
formed. The current crystal structure of SC-(1-325).bovine thrombin reveals that
SC would dock similarly to the bovine proenzyme, whereas the bovine
(pro)thrombin-characteristic residues Arg(144) and Arg(145) would likely
interfere with insertion of the SC N terminus, thus explaining the greatly
reduced activation of bovine ProT.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
Crystal structure of the SC-(1-325)·bovineα-thrombin
complex. The thrombin moiety is shown as a solid surface colored
according to the electrostatic surface potential, from strongly
negative (deep red) to strongly positive (deep blue). The
boomerang-shaped SC molecule is comprised of the N-terminal
domain D1 (helices α[1]^D1 to α[3]^D1) and the C-terminal
domain D2 (helices α[1]^D2 to α[6]^D2) and is represented as a
green ribbon. The anion-binding exosite I, the active site
(Ser^195), and the 148 loop (Trp^148) of bovine α-thrombin are
labeled. The N terminus of SC (defined from ^SCSer^7 onwards) is
placed close to the Ile^16 activation pocket of thrombin but is
disordered in the complexes with bovine and human thrombin and
extends away from the enzyme surface.
|
 |
Figure 4.
Structural characterization of SC-(1-325). A, the two major
helix bundles α[1]^D1-α[3]^D1 (yellow) and α[1]^D2-α[3]^D2
(orange), which are shown superimposed here, are structurally
related. Side chains of all topologically equivalent residues
conserved in both domains are shown with all their non-hydrogen
atoms and labeled. B, close-up of the D1-D2 interdomain
interface, with important residues shown with their full side
chains. Notice the multiple contacts between polar/charged side
chains (e.g. ^SCGlu^54-^SCArg^209), which separate the strictly
conserved ^SCLeu^146 side chain from bulk solvent.
|
 |
|
|
|
| |
The above figures are
reprinted
from an Open Access publication published by the ASBMB:
J Biol Chem
(2006,
281,
1188-1195)
copyright 2006.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
D.Viana,
J.Blanco,
M.A.Tormo-Más,
L.Selva,
C.M.Guinane,
R.Baselga,
J.M.Corpa,
I.Lasa,
R.P.Novick,
J.R.Fitzgerald,
and
J.R.Penadés
(2010).
Adaptation of Staphylococcus aureus to ruminant and equine hosts involves SaPI-carried variants of von Willebrand factor-binding protein.
|
| |
Mol Microbiol,
77,
1583-1594.
|
 |
|
|
|
|
 |
S.Watanabe,
T.Ito,
T.Sasaki,
S.Li,
I.Uchiyama,
K.Kishii,
K.Kikuchi,
R.L.Skov,
and
K.Hiramatsu
(2009).
Genetic diversity of staphylocoagulase genes (coa): insight into the evolution of variable chromosomal virulence factors in Staphylococcus aureus.
|
| |
PLoS One,
4,
e5714.
|
 |
|
|
|
|
 |
T.M.Sabo,
and
M.C.Maurer
(2009).
Biophysical investigation of GpIbalpha binding to thrombin anion binding exosite II.
|
| |
Biochemistry,
48,
7110-7122.
|
 |
|
|
|
|
 |
C.J.Kastrup,
J.Q.Boedicker,
A.P.Pomerantsev,
M.Moayeri,
Y.Bian,
R.R.Pompano,
T.R.Kline,
P.Sylvestre,
F.Shen,
S.H.Leppla,
W.J.Tang,
and
R.F.Ismagilov
(2008).
Spatial localization of bacteria controls coagulation of human blood by 'quorum acting'.
|
| |
Nat Chem Biol,
4,
742-750.
|
 |
|
|
|
|
 |
P.Panizzi,
R.Friedrich,
P.Fuentes-Prior,
K.Richter,
P.E.Bock,
and
W.Bode
(2006).
Fibrinogen substrate recognition by staphylocoagulase.(pro)thrombin complexes.
|
| |
J Biol Chem,
281,
1179-1187.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |
| |